share_log

38 Stocks Moving in Monday's Pre-Market Session

38 Stocks Moving in Monday's Pre-Market Session

38 隻股票在周一的上市前時段移動
Benzinga Real-time News ·  2020/08/31 19:02

Gainers

贏家

  • Aimmune Therapeutics, Inc (NASDAQ:AIMT) shares rose 169.8% to $34.00 in pre-market trading after Nestle SA agreed to acquire the company at an enterprise value of $2.6 billion.
  • Cinedigm Corp. (NASDAQ:CIDM) shares rose 24.1% to $1.12 in pre-market trading. Cinedigm reported a partnership with Canela.TV.
  • TransAtlantic Petroleum Ltd. (NYSE:TAT) rose 23.6% to $0.2901 in pre-market trading. TransAtlantic Petroleum announced plans to pay the upcoming quarterly dividends on its Series A Preferred Shares in Common Shares.
  • UTStarcom Holdings Corp. (NASDAQ:UTSI) rose 23.2% to $1.70 in pre-market trading. UTStarcom reported the launch of a SkyFlux Converged Packet Transport Platform and postponed the release of H1 financial results.
  • FSD Pharma Inc. (NASDAQ:HUGE) rose 20.3% to $3.90 in pre-market trading after the company reported Phase 2 clinical trial IND filing with the FDA to treat patients with COVID-19.
  • VivoPower International PLC (NASDAQ:VVPR) rose 19.3% to $9.85 in pre-market trading after jumping 69% on Friday. The company reported better-than-expected FY20 preliminary results last week.
  • Northern Dynasty Minerals Ltd. (NYSE:NAK) rose 19.1% to $1.08 in pre-market trading after declining around 3% on Friday.
  • Sundial Growers Inc. (NASDAQ:SNDL) rose 16.7% to $0.3999 in pre-market trading after gaining over 7% on Friday. Sundial Growers, earlier during the month, reported a 25.82 million unit offering at $0.50 per unit.
  • Town Sports International Holdings, Inc. (NASDAQ:CLUB) shares rose 15.7% to $0.74 in pre-market trading after gaining over 8% on Friday.
  • Destination XL Group, Inc. (NASDAQ:DXLG) rose 15.6% to $0.41 in pre-market trading after declining 21% on Friday. Destination XL Group, last week, reported better-than-expected Q2 sales.
  • Akcea Therapeutics, Inc. (NASDAQ:AKCA) rose 13.7% to $12.94 in pre-market trading. Akcea Therapeutics and Ionis Pharmaceuticals presented data from the Phase 2 clinical trial of vupanorsen at the ESC Congress 2020, the annual meeting for the European Society of Cardiology.
  • Canaan Inc. (NASDAQ:CAN) rose 11.7% to $2.20 in pre-market trading after the company reported its Q2 earnings results.
  • Tyme Technologies, Inc. (NASDAQ:TYME) shares rose 10.1% to $1.20 in pre-market trading after declining over 4% on Friday. TYME, last week, reported that its oncology research revealed a potential new oral therapy TYPE-19 in 'fight against COVID-19.'
  • Sphere 3D Corp. (NASDAQ:ANY) rose 10% to $2.53 in pre-market trading after jumping 30% on Friday. Sphere 3D, earlier during the month, entered into an agreement for acquisition of a commercial water-as-a-service supplier.
  • Neurocrine Biosciences, Inc (NASDAQ:NBIX) rose 9.3% to $124.99 in pre-market trading. Neurocrine Biosciences, earlier during the month, released upbeat quarterly earnings.
  • HEXO Corp. (NYSE:HEXO) rose 8.7% to $0.78 in pre-market trading.
  • GameStop Corp. (NYSE:GME) rose 8.5% to $5.85 in pre-market trading. GameStop is expected to report Q2 results on September 9.
  • Amarin Corporation plc (NASDAQ:AMRN) rose 8.4% to $7.98 in pre-market trading after the company announced the results from the VASCEPA trial met the primary endpoint.
  • Inovio Pharmaceuticals, Inc. (NASDAQ:INO) rose 8.2% to $13.05 in pre-market trading. The FDA Chairman Stephen Hahn said a COVID-19 vaccine could get emergency approval without Phase 3 trial results, according to the Financial Times.
  • Turquoise Hill Resources Ltd. (NYSE:TRQ) rose 8% to $1.08 in pre-market trading. Turquoise Hill raised its 2021 gold production forecast and filed an updated Oyu Tolgoi Technical Report.
  • Intec Pharma Ltd. (NASDAQ:NTEC) rose 7.7% to $0.3230 in pre-market trading. Intec Pharma, earlier during the month, priced 7.125 million share registered offering at $0.3511 per share.
  • India Globalization Capital, Inc. (NYSE:IGC) rose 7% to $1.39 in pre-market trading. India Globalization Capital reported a Q2 loss during the later part of the month.
  • Gevo, Inc. (NASDAQ:GEVO) shares rose 6.7% to $1.28 in pre-market trading. Gevo shares climbed 10% on Friday after Peak Value IP completed its valuation of the intellectual property of the company and valued it at $412 million.
  • Veoneer, Inc. (NYSE:VNE) shares rose 6.6% to $14.88 in pre-market trading after gaining 9% on Friday as the company and Qualcomm announced plans to collaborate to power next generation ADAS and autonomous driving systems.
  • Color Star Technology Co., Ltd. (NASDAQ:HHT) rose 5.5% to $1.15 in pre-market trading. Color Star Technology shares jumped 23% on Friday after the company announced collaboration with Red Phoenix Entertainment to strategically expand into sports education.
  • Yum China Holdings, Inc. (NYSE:YUMC) rose 5.1% to $59.40 in pre-market trading after the company announced the launch of its Hong Kong secondary listing.
  • 美國免疫治療公司(納斯達克:AIMT)股價在盤前交易中上漲169.8%,至34美元,此前雀巢公司同意以26億美元的企業價值收購該公司。
  • Cinedigm Corp.(納斯達克:CIDM)股價盤前上漲24.1%,至1.12美元。Cinedigm報道了與Canela.TV的合作。
  • 跨大西洋石油有限公司。(紐約證券交易所:塔特)在盤前交易中上漲23.6%至0.2901美元。跨大西洋石油公司宣佈計劃為其普通股A系列優先股支付即將到來的季度股息。
  • UT斯達康控股公司。(納斯達克:烏特西)盤前上漲23.2%,報1.70美元。UT斯達康報告了天流融合分組傳輸平臺的推出,並推遲了H1財報的發佈。
  • FSD製藥公司。(納斯達克:巨大的)在盤前交易中上漲20.3%,至3.9美元,此前該公司報告稱,該公司向美國食品和藥物管理局提交的第二階段臨牀試驗IND申請用於治療新冠肺炎患者。
  • VivoPower International PLC(納斯達克:VVPR)在盤前交易中上漲19.3%,至9.85美元,上週五曾躍升69%。該公司上週公佈的20財年初步業績好於預期。
  • 北方王朝礦業有限公司。(紐約證券交易所:NAK)在盤前交易中上漲19.1%,至1.08美元,上週五下跌約3%。
  • 日規種植者公司。(納斯達克:SNDL)在盤前交易中上漲16.7%,至0.3999美元,上週五漲幅超過7%。本月早些時候,日規種植者公司報告稱,以每套0.5美元的價格出售了2582萬套住房。
  • 城市體育國際控股公司。(納斯達克:俱樂部)股價在週五上漲逾8%後,在盤前交易中上漲15.7%,至0.74美元。
  • 目的地XL集團,Inc.(納斯達克:DXLG)在盤前交易中上漲15.6%,至0.41美元,上週五下跌21%。Destination XL Group上週公佈的第二季度銷售額好於預期。
  • 阿克薩治療公司(納斯達克:AKCA)盤前上漲13.7%,報12.94美元。Akcea治療公司和Ionis製藥公司在2020年歐洲心臟病學會年會ESC大會上公佈了Vupanorsen的2期臨牀試驗數據。
  • 嘉楠科技。(納斯達克:)在盤前交易中上漲11.7%,至2.20美元,此前該公司公佈了第二季度收益業績。
  • 泰姆科技公司(納斯達克:泰姆)股價在週五下跌逾4%後,在盤前交易中上漲10.1%,至1.20美元。泰美公司上週報道,其腫瘤學研究揭示了一種潛在的新口服療法-19型,以對抗CoVID-19。
  • 球體3D公司(納斯達克:任何)在盤前交易中上漲10%,至2.53美元,上週五躍升30%。本月早些時候,Sphere3D達成了一項收購一家商業水即服務供應商的協議。
  • Neurocrine生物科學公司(納斯達克:NBIX)在盤前交易中上漲9.3%,至124.99美元。本月早些時候,Neurocrine Biosciences發佈了樂觀的季度收益。
  • HEXO公司(紐約證券交易所:HEXO)盤前上漲8.7%,報0.78美元。
  • GameStop公司(紐約證券交易所:GME)盤前上漲8.5%,報5.85美元。GameStop預計將於9月9日公佈第二季度業績。
  • Amarin Corporation Plc(納斯達克:AMRN)在盤前交易中上漲8.4%,至7.98美元,此前該公司宣佈Vascepa試驗結果達到主要終點。
  • Inovio製藥公司(納斯達克:伊諾)盤前上漲8.2%,報13.05美元。據英國《金融時報》報道,美國食品和藥物管理局主席斯蒂芬·哈恩表示,新冠肺炎疫苗可能在沒有第三階段試驗結果的情況下獲得緊急批准。
  • 綠松石山資源有限公司。(紐約證券交易所:關税配額)盤前上漲8%,報1.08美元。綠松石山上調了2021年黃金產量預測,並提交了更新的奧尤陶勒蓋技術報告。
  • 英泰克藥業有限公司(納斯達克:NTEC)在盤前交易中上漲7.7%,至0.3230美元。本月早些時候,Intec Pharma將712.5萬股登記發行的股票定價為每股0.3511美元。
  • 印度全球化資本公司(紐約證券交易所:IGC)盤前上漲7%,報1.39美元。印度全球化資本本月下旬報告第二季度虧損。
  • Gevo公司(納斯達克:Gevo)股價在盤前交易中上漲6.7%,至1.28美元。Gevo股價週五攀升10%,此前Peak Value IP完成了對該公司知識產權的估值,估值為4.12億美元。
  • Veoneer公司(紐約證券交易所:VNE)股價在盤前交易中上漲6.6%,至14.88美元,上週五該公司股價上漲9%,該公司和高通宣佈計劃合作為下一代ADAS和自動駕駛系統提供動力。
  • 彩星科技有限公司。(納斯達克:HHT)盤前上漲5.5%,報1.15美元。彩星科技股價週五大漲23%,此前該公司宣佈與紅鳳凰娛樂合作,戰略擴張至體育教育領域。
  • 百勝中國控股有限公司(紐約證券交易所:YUMC)盤前上漲5.1%,報59.40美元,此前該公司宣佈啟動香港二次上市。

 

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

找出今天的市場行情,並提出任何你必須問的問題Benzinga的上市前準備工作.

Losers

失敗者

  • Shiloh Industries, Inc. (NASDAQ:SHLO) shares fell 30.1% to $0.7623 in pre-market trading after the company entered into stock and asset purchase agreement with Grouper Holdings, LLC, a Subsidiary of MiddleGround Capital LLC. The company filed voluntary Chapter 11 petitions to facilitate the transaction.
  • Lipocine Inc. (NASDAQ:LPCN) shares fell 24.2% to $1.25 in pre-market trading after the FDA informed the company that it needs additional time to complete its review of TLANDO's New Drug Application.
  • SemiLEDs Corporation (NASDAQ:LEDS) fell 23.3% to $2.50 in pre-market trading.
  • Ferroglobe PLC (NYSE:GSM) fell 20.2% to $0.4050 in pre-market trading. Ferroglobe is expected to release quarterly earnings after the closing bell today.
  • PEDEVCO Corp. (NYSE:PED) shares fell 19.7% to $1.22 in pre-market trading. PEDEVCO shares tumbled 28% on Friday after the company issued a second status update regarding open letter delivered to Avalon Energy, LLC.
  • Forum Energy Technologies, Inc. (NYSE:FET) fell 14.2% to $0.49 in pre-market trading. Forum Energy Technologies reported Q2 results earlier in the month.
  • Odonate Therapeutics, Inc. (NASDAQ:ODT) fell 10.5% to $16.00 in pre-market trading after gaining 21% on Friday. Odonate Therapeutics, last week, announced a common stock offering.
  • Borr Drilling Limited (NYSE:BORR) fell 9.3% to $0.8710 in pre-market trading. Borr Drilling reported preliminary Q2 results on Friday.
  • CHF Solutions, Inc. (NASDAQ:CHFS) fell 7.9% to $0.34 in pre-market trading. CHF Solutions, earlier during the month, announced pricing of $12.5 million offering at $0.45 per unit.
  • Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) fell 5.8% to $0.4190 in pre-market trading. Hancock Jaffe Laboratories, last week, enrolled the first two patients for its first-in-human CoreoGraft study.
  • Hermitage Offshore Services Ltd. (NYSE:PSV) fell 5.3% to $0.7208 in pre-market trading. Hermitage Offshore Services, on Friday, announced it submitted a request to appeal the NYSE delisting determination.
  • NIO Limited (NYSE:NIO) fell 5.2% to $17.53 in pre-market trading after the company reported pricing of offering of 88,500,000 American Depositary Shares. NIO shares fell 7% on Friday after the company reported a proposed offering of 75 million American depositary shares.
  • 夏洛實業公司(納斯達克:SHLO在盤前交易中,該公司股價下跌30.1%,至0.7623美元,此前該公司與中間地帶資本有限責任公司的子公司Grouper Holdings,LLC達成了股票和資產購買協議。該公司提交了自願根據破產法第11章提交的請願書,以促進交易。
  • 利普西因公司(納斯達克:LPCN)股價在盤前交易中下跌24.2%,至1.25美元,此前FDA通知該公司,它需要更多時間來完成對TLANDO新藥申請的審查。
  • SemiLED公司(納斯達克:LED燈)在盤前交易中下跌23.3%,至2.5美元。
  • Ferrolobe PLC(紐約證券交易所:GSM)在盤前交易中下跌20.2%,至0.4050美元。Ferrolobe預計將在今天收盤後發佈季度收益。
  • PEDEVCO公司(紐約證券交易所:PED)股價在盤前交易中下跌19.7%,至1.22美元。PEDEVCO股價週五暴跌28%,此前該公司就提交給Avalon Energy,LLC的公開信發佈了第二次狀態更新。
  • 論壇能源技術公司(紐約證券交易所:FET)盤前下跌14.2%,報0.49美元。論壇能源技術公司本月早些時候公佈了第二季度業績。
  • 奧多納特治療公司(納斯達克:ODT)在盤前交易中下跌10.5%,至16.00美元,上週五上漲21%。Odonate Treateutics上週宣佈發行普通股。
  • 博爾鑽探有限公司(紐約證券交易所:博爾)在盤前交易中下跌9.3%,至0.8710美元。Borr Drilling上週五公佈了第二季度初步業績。
  • CHF Solutions,Inc.(納斯達克:CHFS)在盤前交易中下跌7.9%,至0.34美元。本月早些時候,CHF Solutions宣佈以每單位0.45美元的價格發行1250萬美元的股票。
  • 漢考克·傑菲實驗室公司(納斯達克:HJLI)在盤前交易中下跌5.8%,至0.4190美元。上週,漢考克·傑菲實驗室招募了第一批兩名患者參加其首個人類CoreoGraft研究。
  • 赫米蒂奇離岸服務有限公司(紐約證券交易所:PSV)在盤前交易中下跌5.3%,至0.7208美元。Hermitage Offshore Services上週五宣佈,它提交了對紐約證交所退市裁決提出上訴的請求。
  • 蔚來有限公司(紐約證券交易所:蔚來)在盤前交易中下跌5.2%,至17.53美元,此前該公司公佈了88,500,000股美國存托股票的發行定價。蔚來週五公佈擬發行7,500萬股美國存托股票後,股價下挫7%。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論